Fluidic medical devices and uses thereof

US9772291B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9772291-B2
Application numberUS-201514727547-A
CountryUS
Kind codeB2
Filing dateJun 1, 2015
Priority dateMay 9, 2005
Publication dateSep 26, 2017
Grant dateSep 26, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention is in the field of medical devices. Specifically, the present invention provides fluidic systems having a plurality of reaction sites surrounded by optical barriers to reduce the amount of optical cross-talk between signals detected from various reaction sites. The invention also provides a method of manufacturing fluidic systems and methods of using the systems.

First claim

Opening claim text (preview).

What is claimed is: 1. An apparatus for detecting an analyte in a biological fluid of a subject, comprising: a plurality of reaction sites; a sample collection unit for introducing a biological fluid in fluid communication with the plurality of reaction sites; a plurality of reactant chambers comprising a plurality of reactants in fluid communication with said plurality of reaction sites, wherein each of said plurality of reaction sites comprise one or more reactants bound thereto for detecting said analyte; a system of fluidic channels to allow said biological fluid and said plurality of reactants to flow in said apparatus; and a wall of at least one of said plurality of reaction sites comprise an optically opaque material so that light will not escape said at least one of said plurality of reaction sites through said wall; wherein said at least one of said plurality of reaction sites comprises a reaction surface with bound reactants around a center of the at least one of said plurality of reaction sites and said bound reactants are spaced apart from a wall of the at least one of said plurality of reaction sites by a concentric ring-shaped area, said at least one of said plurality of reaction sites configured to reduce signal from any unbound conjugates remaining in the at least one of said plurality of reaction sites. 2. A system for detecting an analyte in a biological fluid of a subject, comprising a) a cartridge comprising: a plurality of reaction sites; a sample collection unit for introducing a biological fluid in fluid communication with the plurality of reaction sites, wherein each of said plurality of reaction sites comprise one or more reactants bound thereto for detecting said analyte; a plurality of reactant chambers comprising a plurality of reactants in fluid communication with said plurality of reaction sites, a system of fluidic channels to allow said biological fluid and said plurality of reactants to flow in said cartridge; an identifier on said cartridge; a wall of at least one of said plurality of reaction sites comprises an optically opaque material so that light will not escape said at least one of said plurality of reaction sites through said wall; wherein said at least one of said plurality of reaction sites comprises a reaction surface with bound reactants around a center of the at least one of said plurality of reaction sites and said bound reactants are spaced apart from a wall of the at least one of said plurality of reaction sites by a concentric ring-shaped area, said at least one of said plurality of reaction sites configured to reduce signal from any unbound conjugates remaining in the at least one of said plurality of reaction sites; and b) a reader assembly for receiving the cartridge and comprising: a controller; and an identifier detector to detect the identifier on the cartridge. 3. The system of claim 2 further comprising a pressure burstable seal on at least one of the reactant chambers. 4. The system of claim 2 further comprising a layer of burstable foil enclosing at least one of the reactant chambers. 5. The system of claim 2 further comprising a valve actuation plate on the reader assembly. 6. The system of claim 5 further comprising a non-coring needle on the valve actuation plate. 7. The system of claim 2 further comprising an elastomeric cover on the cartridge. 8. A system for detecting an analyte in a biological fluid of a subject, comprising a) a cartridge comprising: a plurality of reaction sites; a sample collection unit for introducing a biological fluid in fluid communication with the plurality of reaction sites, wherein each of said plurality of reaction sites comprise one or more reactants bound thereto for detecting said analyte; a plurality of reactant chambers comprising a plurality of reactants in fluid communication with said plurality of reaction sites, a system of fluidic channels to allow said biological fluid and said plurality of reactants to flow in said cartridge; an identifier on said cartridge; a wall of at least one of said plurality of reaction sites comprises an optically opaque material so that light will not escape said at least one of said plurality of reaction sites through said wall; wherein said at least one of said plurality of reaction sites comprises a reaction surface with bound reactants around a center of the at least one of said plurality of reaction sites and said bound reactants are spaced apart from a wall of the at least one of said plurality of reaction sites by a concentric ring-shaped area, said at least one of said plurality of reaction sites configured to reduce signal from any unbound conjugates remaining in the at least one of said plurality of reaction sites; and b) a reader assembly for receiving the cartridge and comprising: a controller; an identifier detector to detect the identifier on the cartridge; and a communication assembly, wherein said identifier detector communicates with the communication assembly that is controlled by said controller.

Assignees

Inventors

Classifications

  • for local operation · CPC title

  • pierceable, e.g. films, membranes · CPC title

  • Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing (measuring or testing processes involving enzymes or microorganisms, compositions or test papers therefor; processes for forming such compositions, condition responsive control in microbiological or enzymological processes C12Q) · CPC title

  • Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing · CPC title

  • G01N21/76Primary

    Chemiluminescence; Bioluminescence · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9772291B2 cover?
This invention is in the field of medical devices. Specifically, the present invention provides fluidic systems having a plurality of reaction sites surrounded by optical barriers to reduce the amount of optical cross-talk between signals detected from various reaction sites. The invention also provides a method of manufacturing fluidic systems and methods of using the systems.
Who is the assignee on this patent?
Theranos Inc
What technology area does this patent fall under?
Primary CPC classification G01N21/76. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).